Clinical Trial Update: Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin [Phase 1]

View source ↗

Summary

Phase 1 ascending multiple-dose study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of evolocumab in adults with hyperlipidemia on stab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Amgen | Conditions: Hyperlipidemia | Phase 1 | Status: COMPLETED | Results posted: 2015-10-22